316 related articles for article (PubMed ID: 33810287)
1.
Villena J; Li C; Vizoso-Pinto MG; Sacur J; Ren L; Kitazawa H
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33810287
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunization with lactiplantibacillus plantarum-displaying recombinant SARS-CoV-2 epitopes on the surface induces humoral and mucosal immune responses in mice.
Hwang IC; Valeriano VD; Song JH; Pereira M; Oh JK; Han K; Engstrand L; Kang DK
Microb Cell Fact; 2023 May; 22(1):96. PubMed ID: 37161468
[TBL] [Abstract][Full Text] [Related]
3. Alterations in the gut microbiome and its metabolites are associated with the immune response to mucosal immunization with
Hwang IC; Vasquez R; Song JH; Engstrand L; Valeriano VD; Kang DK
Front Cell Infect Microbiol; 2023; 13():1242681. PubMed ID: 37705931
[TBL] [Abstract][Full Text] [Related]
4. Immunobiotic Lactobacilli Improve Resistance of Respiratory Epithelial Cells to SARS-CoV-2 Infection.
Islam MA; Albarracin L; Tomokiyo M; Valdez JC; Sacur J; Vizoso-Pinto MG; Andrade BGN; Cuadrat RRC; Kitazawa H; Villena J
Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578229
[TBL] [Abstract][Full Text] [Related]
5. Mucosal IgA response elicited by intranasal immunization of Lactobacillus plantarum expressing surface-displayed RBD protein of SARS-CoV-2.
Li L; Wang M; Hao J; Han J; Fu T; Bai J; Tian M; Jin N; Zhu G; Li C
Int J Biol Macromol; 2021 Nov; 190():409-416. PubMed ID: 34499954
[TBL] [Abstract][Full Text] [Related]
6. A micro-sized vaccine based on recombinant
Li L; Hao J; Jiang Y; Hao P; Gao Y; Chen J; Zhang G; Jin N; Wang M; Li C
Acta Pharm Sin B; 2023 Feb; 13(7):3168-76. PubMed ID: 36852097
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 spike-FLIPr fusion protein plus lipidated FLIPr protects against various SARS-CoV-2 variants in hamsters.
Hsieh M-S; Hsu C-W; Liao H-C; Lin C-L; Chiang C-Y; Chen M-Y; Liu S-J; Liao C-L; Chen H-W
J Virol; 2024 Feb; 98(2):e0154623. PubMed ID: 38299865
[TBL] [Abstract][Full Text] [Related]
8. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
Nagai M; Moriyama M; Ichinohe T
mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
[TBL] [Abstract][Full Text] [Related]
9. The Modulation of Mucosal Antiviral Immunity by Immunobiotics: Could They Offer Any Benefit in the SARS-CoV-2 Pandemic?
Villena J; Kitazawa H
Front Physiol; 2020; 11():699. PubMed ID: 32670091
[TBL] [Abstract][Full Text] [Related]
10. A Bacteriophage-Based, Highly Efficacious, Needle- and Adjuvant-Free, Mucosal COVID-19 Vaccine.
Zhu J; Jain S; Sha J; Batra H; Ananthaswamy N; Kilgore PB; Hendrix EK; Hosakote YM; Wu X; Olano JP; Kayode A; Galindo CL; Banga S; Drelich A; Tat V; Tseng CK; Chopra AK; Rao VB
mBio; 2022 Aug; 13(4):e0182222. PubMed ID: 35900097
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
Oh SH; Kim SH; Jeon JH; Kim EB; Lee NK; Beck S; Choi YJ; Kang SK
Vaccine; 2021 Jul; 39(30):4072-4081. PubMed ID: 34127296
[TBL] [Abstract][Full Text] [Related]
12.
Baillo A; Villena J; Albarracín L; Tomokiyo M; Elean M; Fukuyama K; Quilodrán-Vega S; Fadda S; Kitazawa H
Microorganisms; 2022 Dec; 11(1):. PubMed ID: 36677354
[TBL] [Abstract][Full Text] [Related]
13. Intranasal delivery of an adenovirus-vector vaccine co-expressing a modified spike protein and a genetic adjuvant confers lasting mucosal immunity against SARS-CoV-2.
Jung HE; Ku KB; Kang BH; Park JH; Kim HC; Kim KD; Lee HK
Antiviral Res; 2023 Aug; 216():105656. PubMed ID: 37327877
[TBL] [Abstract][Full Text] [Related]
14. Vaccination and Omicron BA.1/BA.2 Convalescence Enhance Systemic but Not Mucosal Immunity against BA.4/5.
Diem G; Jäger M; Dichtl S; Bauer A; Lass-Flörl C; Reindl M; Wilflingseder D; Posch W
Microbiol Spectr; 2023 Jun; 11(3):e0516322. PubMed ID: 37098903
[TBL] [Abstract][Full Text] [Related]
15. Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.
Kuczkowska K; Kleiveland CR; Minic R; Moen LF; Øverland L; Tjåland R; Carlsen H; Lea T; Mathiesen G; Eijsink VGH
Appl Environ Microbiol; 2017 Jan; 83(2):. PubMed ID: 27815271
[TBL] [Abstract][Full Text] [Related]
16. A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective Immunity.
Bellier B; Saura A; Luján LA; Molina CR; Luján HD; Klatzmann D
Front Immunol; 2022; 13():837443. PubMed ID: 35281065
[TBL] [Abstract][Full Text] [Related]
17. A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2.
Wang M; Fu T; Hao J; Li L; Tian M; Jin N; Ren L; Li C
Int J Biol Macromol; 2020 Oct; 160():736-740. PubMed ID: 32485251
[TBL] [Abstract][Full Text] [Related]
18. In vivo monitoring of Lactiplantibacillus plantarum in the nasal and vaginal mucosa using infrared fluorescence.
Silva-Bea S; Francisco-Tomé M; Cabrera-Alvargonzález JJ; Potel C; Álvarez M; Pérez S; Regueiro B; Cabral MP
Appl Microbiol Biotechnol; 2022 Sep; 106(18):6239-6251. PubMed ID: 35999391
[TBL] [Abstract][Full Text] [Related]
19. Boosting Vaccine-Elicited Respiratory Mucosal and Systemic COVID-19 Immunity in Mice With the Oral
Xu J; Ren Z; Cao K; Li X; Yang J; Luo X; Zhu L; Wang X; Ding L; Liang J; Jin D; Yuan T; Li L; Xu J
Front Nutr; 2021; 8():789242. PubMed ID: 35004816
[TBL] [Abstract][Full Text] [Related]
20. Exosome-Based Multivalent Vaccine: Achieving Potent Immunization, Broadened Reactivity, and Strong T-Cell Responses with Nanograms of Proteins.
Cacciottolo M; Nice JB; Li Y; LeClaire MJ; Twaddle R; Mora CL; Adachi SY; Chin ER; Young M; Angeles J; Elliott K; Sun M
Microbiol Spectr; 2023 Jun; 11(3):e0050323. PubMed ID: 37093009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
